{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:30:16Z","timestamp":1794457816879,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejogrb.2026.115512","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:35:19Z","timestamp":1792424119000},"page":"115512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical significance and diagnostic performance of maternal circulating soluble ST2 in preeclampsia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"327","author":[{"given":"Artha Maressa Theodora","family":"Simanjuntak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wirya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komang Indra Parama","family":"Arta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frengki Prabowo Saputro","family":"Wijayanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115512_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejogrb.2026.115512_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2025.1706009","article-title":"Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: a systematic review and meta-analysis","volume":"7","author":"Vera-Ponce","year":"2025","journal-title":"Front Reprod Health"},{"key":"10.1016\/j.ejogrb.2026.115512_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"7 Suppl","key":"10.1016\/j.ejogrb.2026.115512_b0025","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the international ST2 consensus panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2026.115512_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024463","article-title":"ST2 and IL-33 in pregnancy and pre-eclampsia","volume":"6","author":"Granne","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2026.115512_b0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/14767058.2017.1286319","article-title":"Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia \u2013 a longitudinal study","volume":"31","author":"Romero","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0040","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70123","article-title":"Cardiovascular biomarkers and preeclampsia: a narrative review","volume":"56","author":"Ullmo","year":"2026","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejogrb.2026.115512_b0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2026.115512_b0050","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Available from: www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.ejogrb.2026.115512_b0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.ejogrb.2026.115512_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"10.1016\/j.ejogrb.2026.115512_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Method"},{"issue":"7 Suppl","key":"10.1016\/j.ejogrb.2026.115512_b0075","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/j.amjcard.2015.01.035","article-title":"Soluble ST2 \u2013 analytical considerations","volume":"115","author":"Mueller","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2026.115512_b0080","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2026.115512_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ejogrb.2026.115512_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2026.115512_b0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2026.115512_b0105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/01443615.2021.1991293","article-title":"ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia","volume":"42","author":"Atakul","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2026.115512_b0110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3109\/14767058.2013.784256","article-title":"Maternal plasma concentrations of sST2 and angiogenic\/anti-angiogenic factors in preeclampsia","volume":"26","author":"Stampalija","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0115","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2022.2153034","article-title":"Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia","volume":"36","author":"Kanninen","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0120","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41440-021-00650-0","article-title":"Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia","volume":"44","author":"Liu","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ejogrb.2026.115512_b0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14767058.2019.1609934","article-title":"Elevated soluble-St2 concentrations in preeclampsia correlate with echocardiographic parameters of diastolic dysfunction and return to normal values one year after delivery","volume":"34","author":"Mugerli","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.placenta.2023.08.062","article-title":"Prediction of maternal and foetal outcomes among patients with preeclampsia using circulatory biomarkers (MMP-9 & ST2) \u2013 a prospective cohort study","volume":"142","author":"Samal","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115512_b0135","article-title":"Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia","volume":"13","author":"Sasmaya","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"10.1016\/j.ejogrb.2026.115512_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.preghy.2013.02.002","article-title":"Measurement of sST2 is comparable to PlGF in the diagnosis of early-onset pre-eclampsia","volume":"3","author":"Southcombe","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115512_b0145","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/jch.14579","article-title":"The correlation between maternal serum sST2, IL-33 and NT-proBNP concentrations and occurrence of pre-eclampsia in twin pregnancies: a longitudinal study","volume":"24","author":"Xiang","year":"2022","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115512_b0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejogrb.2021.01.039","article-title":"Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis","volume":"258","author":"Margioula-Siarkou","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2026.115512_b0155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study","volume":"71","author":"Agrawal","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2026.115512_b0160","article-title":"Serum biomarkers for the prediction and diagnosis of preeclampsia: a systematic meta-analysis of diagnostic accuracy","volume":"13","author":"Li","year":"2026","journal-title":"Front Med"},{"key":"10.1016\/j.ejogrb.2026.115512_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-023-03696-9","article-title":"Relationship between serum soluble suppression of tumorigenicity (ST) 2 and global longitudinal strain in early onset preeclampsia","volume":"24","author":"Prameswari","year":"2024","journal-title":"BMC Cardiovasc Disord"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:49:15Z","timestamp":1794455355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526005804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0301211526005804"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115512","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance and diagnostic performance of maternal circulating soluble ST2 in preeclampsia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115512"}}